Ainos Balance Sheet Health
Financial Health criteria checks 3/6
Ainos has a total shareholder equity of $18.0M and total debt of $12.3M, which brings its debt-to-equity ratio to 68.1%. Its total assets and total liabilities are $31.4M and $13.3M respectively.
Key information
68.1%
Debt to equity ratio
US$12.27m
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.16m |
| Equity | US$18.02m |
| Total liabilities | US$13.35m |
| Total assets | US$31.37m |
Recent financial health updates
We Think Ainos (NASDAQ:AIMD) Has A Fair Chunk Of Debt
Mar 10
Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
Aug 28Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
May 15Recent updates
We Think Ainos (NASDAQ:AIMD) Has A Fair Chunk Of Debt
Mar 10Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
Aug 28Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
May 15Ainos rises 50% on positive data from animal study trial of Veldona to treat COVID-19
Sep 30Ainos stock rises on FDA filing for starting phase 2 trial of Veldona for COVID-19
Aug 24Amarillo Biosciences GAAP EPS of -$0.01, revenue of $636.62M
Aug 15Financial Position Analysis
Short Term Liabilities: AIMD's short term assets ($5.6M) exceed its short term liabilities ($4.1M).
Long Term Liabilities: AIMD's short term assets ($5.6M) do not cover its long term liabilities ($9.2M).
Debt to Equity History and Analysis
Debt Level: AIMD's net debt to equity ratio (39.5%) is considered satisfactory.
Reducing Debt: AIMD's debt to equity ratio has reduced from 476.1% to 68.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AIMD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AIMD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 37.9% each year